Contracts › 75F40125C00027
75F40125C00027: Direct 8(A) Award, Stand-Alone, Labor-Hour (LH) Type Contract for Food and Drug Administration for Oncology Center of Excellence Benefits Risk Professional Services.
Awarded to Aneon Brillient, Llc by Food and Drug Administration (FDA).
$2.2Mobligated
$2.2Mpotential value
11 August 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125C00027 |
|---|---|
| Awardee | Aneon Brillient, Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 Administrative Management and General Management Consulting Services |
| PSC | R699 Support- Administrative: Other |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 04 June 2025 to 11 August 2026 |
| Potential end | 11 August 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541611 contracts · All expiring contracts · USASpending record